Insider transactions

Myriam Curet

CIK 1632901 · EVP & Chief Medical Officer · last filed 2026-08-03

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure
$1.23M
Companies
5
Total Filings
152
Lifetime Open-Market Net
-$89.35M

Charts

Trading activity, where the exposure sits, and each trade against the stock price.

ISRG price and trades

Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.

Shares held

Shares owned after each reported transaction on this company (direct holdings as reported).

Open-market buying and selling

by month

Dollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.

Exposure by company

latest
OfficerDirector10% owner* stale (no filing in 3 yrs)

Most recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.

Filer Profile

Reported Address
1020 KIFER ROAD
SUNNYVALE, CA 94086
Phone
(408) 523-7587
State of Incorporation
DE
Formerly Known As
Myriam Curet (2015–2021)
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
MOBI Director — $11.17 — $0 1 2026-08-03
STXS Director 435,161 $1.03 $448.2K $0 10 2026-07-01
INSP Director 6,927 $70.39 $487.6K $188 5 2026-05-04
ISRG EVP & Chief Medical Officer 514 $445.03 $228.7K -$89.24M 100 2026-03-11
NKTR Director 1,828 $37.94 $69.3K -$109.2K 8 2023-09-20

Recent Filings · Page 9 of 16

152 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2022-07-01 STXS Grant (A) +15,527 $0 EDGAR
2022-04-27 ISRG Mixed −144 -$677.9K EDGAR
2022-03-02 ISRG Mixed −2,000 -$579.9K EDGAR
2022-03-01 ISRG Mixed +2,000 -$574.4K EDGAR
2022-02-17 ISRG Mixed — -$1.37M EDGAR
2022-01-26 ISRG Mixed +3,000 -$44.8K EDGAR
2022-01-04 STXS Grant (A) +9,335 $0 EDGAR
2021-10-26 ISRG Mixed — -$1.38M EDGAR
2021-09-24 NKTR Mixed +6,535 -$65.2K EDGAR
2021-09-10 ISRG Mixed — -$3.32M EDGAR
Showing 81–90 of 152
Page 9 of 16
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.